Christopher E. Wee

Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution

C. Weight, Ross S. Liao, S. Ganguly, 2023, Frontiers in Endocrinology.

Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events.

T. Gilligan, M. Ornstein, A. Nizam, 2023, Clinical genitourinary cancer.

Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening Strategies

M. de Andrade, A. Bryce, R. McWilliams, 2021, JCO oncology practice.

Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab

T. Gilligan, M. Ornstein, C. Diaz-Montero, 2024, Clinical Genitourinary Cancer.

Management of testicular germ cell tumors.

T. Gilligan, Christopher E. Wee, 2023, Clinical advances in hematology & oncology : H&O.

Risk of Thromboembolism in Patients Receiving Immunotherapy-Based Combinations as Front-Line Therapy for Metastatic Renal Cell Carcinoma.

A. Khorana, T. Gilligan, M. Ornstein, 2023, Clinical genitourinary cancer.